Literature DB >> 18599482

The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.

Brett J Winborn1, Sue M Travis, Sokol V Todi, K Matthew Scaglione, Ping Xu, Aislinn J Williams, Robert E Cohen, Junmin Peng, Henry L Paulson.   

Abstract

Ubiquitin chain complexity in cells is likely regulated by a diverse set of deubiquitinating enzymes (DUBs) with distinct ubiquitin chain preferences. Here we show that the polyglutamine disease protein, ataxin-3, binds and cleaves ubiquitin chains in a manner suggesting that it functions as a mixed linkage, chain-editing enzyme. Ataxin-3 cleaves ubiquitin chains through its amino-terminal Josephin domain and binds ubiquitin chains through a carboxyl-terminal cluster of ubiquitin interaction motifs neighboring the pathogenic polyglutamine tract. Ataxin-3 binds both Lys(48)- or Lys(63)-linked chains yet preferentially cleaves Lys(63) linkages. Ataxin-3 shows even greater activity toward mixed linkage polyubiquitin, cleaving Lys(63) linkages in chains that contain both Lys(48) and Lys(63) linkages. The ubiquitin interaction motifs regulate the specificity of this activity by restricting what can be cleaved by the protease domain, demonstrating that linkage specificity can be determined by elements outside the catalytic domain of a DUB. These findings establish ataxin-3 as a novel DUB that edits topologically complex chains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599482      PMCID: PMC2546540          DOI: 10.1074/jbc.M803692200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.

Authors:  Xiaoyan Zhong; Randall N Pittman
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

2.  The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.

Authors:  Barrington Burnett; Fusheng Li; Randall N Pittman
Journal:  Hum Mol Genet       Date:  2003-10-14       Impact factor: 6.150

Review 3.  Pathogenesis of polyglutamine disorders: aggregation revisited.

Authors:  Andrej Michalik; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2003-10-15       Impact factor: 6.150

4.  A proteomics approach to understanding protein ubiquitination.

Authors:  Junmin Peng; Daniel Schwartz; Joshua E Elias; Carson C Thoreen; Dongmei Cheng; Gerald Marsischky; Jeroen Roelofs; Daniel Finley; Steven P Gygi
Journal:  Nat Biotechnol       Date:  2003-07-20       Impact factor: 54.908

5.  Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.

Authors:  Ellen W Doss-Pepe; Edward S Stenroos; William G Johnson; Kiran Madura
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics.

Authors:  Hartmut Scheel; Stefan Tomiuk; Kay Hofmann
Journal:  Hum Mol Genet       Date:  2003-08-27       Impact factor: 6.150

7.  Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.

Authors:  Yaohui Chai; Sarah Shoesmith Berke; Robert E Cohen; Henry L Paulson
Journal:  J Biol Chem       Date:  2003-11-05       Impact factor: 5.157

8.  Molecular clearance of ataxin-3 is regulated by a mammalian E4.

Authors:  Masaki Matsumoto; Masayoshi Yada; Shigetsugu Hatakeyama; Hiroshi Ishimoto; Teiichi Tanimura; Shoji Tsuji; Akira Kakizuka; Masatoshi Kitagawa; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

Review 9.  Polyglutamines placed into context.

Authors:  Albert R La Spada; J Paul Taylor
Journal:  Neuron       Date:  2003-06-05       Impact factor: 17.173

Review 10.  Toxic proteins in neurodegenerative disease.

Authors:  J Paul Taylor; John Hardy; Kenneth H Fischbeck
Journal:  Science       Date:  2002-06-14       Impact factor: 47.728

View more
  133 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.

Authors:  Li Zeng; Sara J Tallaksen-Greene; Bo Wang; Roger L Albin; Henry L Paulson
Journal:  J Huntingtons Dis       Date:  2013

3.  Most mutations that cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16) destabilize the protein quality-control E3 ligase CHIP.

Authors:  Adam J Kanack; Oliver J Newsom; Kenneth Matthew Scaglione
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

Review 4.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin.

Authors:  Haopeng Wang; Atsushi Matsuzawa; Scott A Brown; JingRan Zhou; Cliff S Guy; Ping-Hui Tseng; Karen Forbes; Thomas P Nicholson; Paul W Sheppard; Hans Häcker; Michael Karin; Dario A A Vignali
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

6.  Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37.

Authors:  Hidetaka Tanno; Takeshi Shigematsu; Shuhei Nishikawa; Akira Hayakawa; Kimitoshi Denda; Toshiaki Tanaka; Masayuki Komada
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

7.  Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.

Authors:  Joanna R Sutton; Jessica R Blount; Kozeta Libohova; Wei-Ling Tsou; Gnanada S Joshi; Henry L Paulson; Maria do Carmo Costa; K Matthew Scaglione; Sokol V Todi
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

Review 8.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

9.  Mass spectrometric analysis of type 1 inositol 1,4,5-trisphosphate receptor ubiquitination.

Authors:  Danielle A Sliter; Kazuishi Kubota; Donald S Kirkpatrick; Kamil J Alzayady; Steven P Gygi; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.